Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.85
-0.12 (-1.51%)
At close: Feb 11, 2026, 4:00 PM EST
7.85
0.00 (0.00%)
After-hours: Feb 11, 2026, 4:00 PM EST
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $716.22 million as of February 11, 2026. Its market cap has decreased by -26.67% in one year.
Market Cap
716.22M
Enterprise Value
648.24M
1-Year Change
-26.67%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $716.22M, an increase of 38.96%. That is a compound annual growth rate of 15.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 724.40M | 12.89% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 768.65M |
| MapLight Therapeutics | 766.78M |
| Nektar Therapeutics | 754.06M |
| KalVista Pharmaceuticals | 747.07M |
| Bright Minds Biosciences | 740.63M |
| Cullinan Therapeutics | 698.87M |
| Kura Oncology | 676.13M |
| Fulcrum Therapeutics | 674.88M |